We also observed a general improvement of hepatic metabolism, in particular on bile acid and fatty acid metabolism (Figure 3A), in line with the decrease of liver steatosis observed in Prdx2-KO mice (Figure 2). Here, PRDX2 is linked to fatty liver disease.